An observational study in BPH With Urinary Obstruction, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to male participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2023-10-26.
Sponsored by Mansoura University · Observational
This study will be conducted to estimate readmission rate and reasons for readmission after all modalities of endoscopic transurethral surgeries for treatment of BOO secondary to BPH in the last 20 years.
Computerized patient information system (PIS) of Urology and Nephrology Center (UNC) and database of prostate unit of UNC will be reviewed for all preoperative, intraoperative and post discharge data. All follow up visits will be traced for outcome measurement. Patients with no hospital follow up visit will be contacted by phone and interrogated about their LUTS control state, ongoing medication and history of secondary procedures.
Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
They will be the subdivided into four groups:
Group I: Patient who underwent transurethral incision of the prostate (TUIP) using electrical current or laser beam. Group II: Patient who underwent transurethral resection of the prostate (TURP) using momopolar or bipolar current. Group III: Patient who underwent vaporization of the prostate using plasma or laser energy (GreenLight PVP and Thulium vaporization of the prostate). Group IV: Patient who underwent anatomical endoscopic enucleation of the prostate (AEEP) using Holmium, Thulium or GreenLight laser or bipolar current.
Men who underwent transurethral prostatic surgery for BPH causing BOO at Urology and Nephrology Center, Mansoura University, Egypt from Jun. 2005 to Dec. 2024.
Exclusion Criteria:
Patients who underwent TUIP using electrocautery or Laser.
Procedure: TUIP
Patients who underwent TURP using monopolar or bipolar electrocautery.
Procedure: TURP
Patient who underwent vaporization of the prostate using plasma or laser energy (GreenLight PVP and Thulium vaporization of the prostate).
Procedure: Prostate Vaporization
Patient who underwent anatomical endoscopic enucleation of the prostate (AEEP) using Holmium, Thulium or GreenLight laser or bipolar current.
Procedure: AEEP
Patient who underwent transurethral incision of the prostate (TUIP) using electrical current or laser beam.
Patient who underwent transurethral resection of the prostate (TURP) using momopolar or bipolar current.
Patient who underwent vaporization of the prostate using plasma or laser energy (GreenLight PVP and Thulium vaporization of the prostate).
Patient who underwent anatomical endoscopic enucleation of the prostate (AEEP) using Holmium, Thulium or GreenLight laser or bipolar current.
The need for post discharge hospital readmission.
The need for post discharge hospital readmission after surgery.
Time frame: 90 days
Differences of readmission rates
Difference of readmission rates for different modalities of transuretheral prostatic surgery.
Time frame: 90 days
Change in the causes of readmission over time.
Change in the causes of readmission over time.
Time frame: 20 years
Causes and predictors of readmission.
Causes and predictors of readmission.
Time frame: 90 days
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mansoura University